Professor Anne Mills
DCMG CBE MA DHSA PhD FMedSci FRS
Deputy Director & Provost
and Professor of Health Economics and Policy
I have researched and published widely in the fields of health economics and health systems in low and middle income countries. I continue to be involved in research on universal coverage developments in Tanzania, South Africa and Thailand, and on strengthening services for mothers and children. I have had continuing involvement in supporting capacity development in health economics in low and middle income country universities and research institutions. I have advised multilateral, bilateral and government agencies on numerous occasions; was a member of WHO’s Commission on Macroeconomics and Health; and co-chaired one of the two Working Groups for the 2009 High Level Taskforce on Innovative International Finance for Health Systems co-chaired by Gordon Brown. I was President of the International Health Economics Association (iHEA) for 2012-13.
2006 Awarded CBE for services to medicine and elected Foreign Associate of the US Institute of Medicine
2009 Elected Fellow of the UK Academy of Medical Sciences and recipient of the Prince Mahidol Award in the field of medicine
2013 Elected Fellow of the Royal Society
2015 Made a Dame in the Queen’s New Year’s Honours for services to international health
I supervise research degree students in a variety of areas of health economics and health systems including contractual relationships in health care; national health insurance; non-formal insurance and private markets for health; I provide input to masters' degree teaching in the areas of health economics and health systems.
My main research interests are:
(1) issues concerned with the financing and organisation of health care in low and middle income countries, especially the impact of different systems of finance and provision on demand, utilization, equity and efficiency, the relevance of provider markets and contracting-out in various developing country contexts. I am also interested in health insurance systems, particularly their relationship with and impact on the private health sector.
(2) the economics of tropical disease control, especially malaria. This extends beyond work on the cost-effectiveness of malaria control to an interest in how activities in the private sector affect malaria control and can be re-shaped to be more supportive
(3) general issues of how to encourage the use of economic thinking and analysis in decision making. I am a member of the joint Wellcome Trust, DFID, MRC, ESRC Health Systems Research funding panel and of the MRC Global Health Group.